U.S. Markets closed
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow 30

    34,584.88
    -166.44 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.96 (-0.91%)
     
  • Russell 2000

    2,236.87
    +3.96 (+0.18%)
     
  • Crude Oil

    71.96
    -0.65 (-0.90%)
     
  • Gold

    1,753.90
    -2.80 (-0.16%)
     
  • Silver

    22.42
    -0.33 (-1.44%)
     
  • EUR/USD

    1.1732
    -0.0040 (-0.3402%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • Vix

    20.81
    +2.12 (+11.34%)
     
  • GBP/USD

    1.3737
    -0.0059 (-0.4286%)
     
  • USD/JPY

    109.8950
    +0.1770 (+0.1613%)
     
  • BTC-USD

    48,384.32
    +329.87 (+0.69%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.62%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Moderna Stock Surges on News of Inclusion Into S&P 500 Next Week

·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

By Dhirendra Tripathi

Investing.com – Moderna (NASDAQ:MRNA) stock was up more than 8% in Friday’s premarket trading on news of its inclusion in S&P 500 Index from next week.

Being part of the S&P 500 means passive investors who manage trillions of dollars will have to include it in their portfolios, as it will now be part of more fund schemes benchmarked against the index.

Tesla (NASDAQ:TSLA) was the last noteworthy addition to the index, joining it in late 2020.  

The inclusion in the index is another triumph for the biotech company whose pioneering work on so-called messenger RNA has allowed it to bring to market one of the most effective vaccines against COVID-19 vaccine. The company says the mRNA technology may have many other applications including vaccines against other diseases, as well as drugs for heart disease, cancer and rare genetic conditions.

Moderna will replace Alexion Pharmaceuticals in the index before the opening of trade on July 21. Alexion (NASDAQ:ALXN) is set to be acquired by U.K.'s AstraZeneca (NASDAQ:AZN).

Shares of Moderna have more than trebled over the past 12 months, sending the Cambridge, Massachusetts-based company’s market value above $100 billion for the first time this week, according to Bloomberg.

 

 

Related Articles

Paris Club calls for Ethiopia creditor committee to be formed

World shares steady, U.S. yields hover near lows ahead of fresh data